Our AHSC cardiovascular programme is focussed on developing innovative approaches to prevent heart disease and creating new medicines and devices that will benefit of patients with or at risk of heart disease or stroke.

Our AHSN cardiovascular programme compliments this by working to improve the cardiac health of our patient population through partnerships that make a real difference in population and place-based care.

Cardiovascular disease programme (AHSN)

Two thirds of premature deaths in the UCLPartners population of around six million people are caused by cancer or heart disease. The objective of the CVD programme is to support the our partners transformation towards place based systems of care that will deliver improved population health and greater sustainability by focusing on cardiovascular prevention and new models of care.

Our CVD work currently focusses on Atrial Fibrillation (AF). Read more about our AF work.

Programme leadership

Dr John Robson, Primary Care Lead and Sotiris Anotniou, Pharmacy Lead

For more information about our cardiovascular disease programme please contact Geraldine Long, Project Manager for AF.

Cardiovascular programme (AHSC)

Our cardiovascular programme aims to achieve maximum global, national and regional impact for the benefit of patients with or at risk of heart disease or stroke.

The cardiovascular programme draws on a multitude of skills and resources that exist within the partnership. Specifically it brings together the research strengths of UCL and Queen Mary University London (QMUL); the translational infrastructure of University College London Hospital (UCLH), Moorfields Eye Hospital NHS Foundation Trust, Great Ormond Street Hospital for Children NHS Foundation Trust and Barts Health NHS Trust; and the clinical expertise of three specialist cardiac hospitals (UCLH’s Heart Hospital, Barts Heart Centre at St Bartholomew’s Hospital and the Royal Free Hospital).

The cardiovascular programme has two workstreams. You can read more about these below.

Joint Translational Cardiovascular Institute (JTCI)

Barts Heart Centre

Programme leadership

Professor Steffen Petersen, Professor of Cardiovascular Medicine, Queen Mary University of London